• Oct 5, 2026

  $108.31-1.41%

  The shares fell 1.41% while comparable listed companies in Biological Products rose 3.02% on average, with all 6 of them higher [1]. The decline was therefore not shared by the cohort, which moved the other way [1].

  • 1Peer group

• Oct 2, 2026

  $109.86+2.73%

  Comparable listed companies in Biological Products (No Diagnostic Substances) rose 0.89% on average, with 4 of 6 rising and 1 falling [1]. The company's 2.73% gain was larger than the cohort's average, so only part of the move was shared with those companies [1].

  • 1Peer group

• Oct 1, 2026

  $106.94-3.13%

  Comparable listed companies in Biological Products fell 1.99% on average on the day, with 5 of 6 falling [1]. The company's 3.13% decline came alongside that sector weakness and was larger than the cohort average [1].

  • 1Peer group

• Sep 30, 2026

  $110.40-1.04%

• Sep 29, 2026

  $111.56-1.18%

  Comparable listed companies in biological products rose 1.04% on average, with 4 of 6 rising and 2 falling [1]. The company fell 1.18%, so its decline was not shared by the cohort, which moved higher [1].

  • 1Peer group

• Sep 28, 2026

  $112.89-0.89%

• Sep 25, 2026

  $113.90-1.15%

Closing prices for HALO. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.